Inhibition of erythropoiesis in malaria anemia: Role of hemozoin and hemozoin-generated 4-hydroxynonenal

Blood

Volumn 116, Issue 20, 2010, Pages 4328-4337

  Skorokhod, Oleksii A ^a   Caione, Luisa ^a   Marrocco, Tiziana ^a   Migliardi, Giorgia ^a   Barrera, Valentina ^a   Arese, Paolo ^a   Piacibello, Wanda ^a   Schwarzer, Evelin ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; CD71 ANTIGEN; CYCLIN A; ERYTHROPOIETIN RECEPTOR; GLYCOPHORIN A; HEMOGLOBIN; HEMOZOIN; INTERLEUKIN 3 RECEPTOR; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN; STEM CELL FACTOR RECEPTOR;

ANEMIA; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL STRAIN K 562; CONTROLLED STUDY; ERYTHROID CELL; ERYTHROPOIESIS; HUMAN; HUMAN CELL; MALARIA ANEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

EID: 78549286042     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-03-272781     Document Type: Article

References (50)

1. Casals-Pascual C, Roberts DJ. Severe malarial anaemia. Curr Mol Med. 2006;6(2):155-168.
2. Chang KH, Tam M, Stevenson MM. Inappropriately low reticulocytosis in severe malarial anemia correlates with suppression in the development of late erythroid precursors. Blood. 2004;103(10):3727-3735. (Pubitemid 38596288)
3. Burgmann H, Looareesuwan S, Kapiotis S, et al. Serum levels of erythropoietin in acute Plasmodium falciparum malaria. Am J Trop Med Hyg. 1996;54(3):280-283. (Pubitemid 26100716)
4. Dörmer P, Dietrich M, Kern P, Horstmann RD. Ineffective erythropoiesis in acute human P. falciparum malaria. Blut. 1983;46(5):279-288.
5. Knüttgen HJ. Das verhalten der Makrophagen und die Phagozytose von Parasiten im Knochenmark bei Malaria tropica. Z Tropenmed Parasit. 1961;12:161-171.
6. Phillips RE, Looareesuwan S, Warrell DA, et al. The importance of anaemia in cerebral and uncomplicated falciparum malaria: role of complications, dyserythropoiesis and iron sequestation. Q J Med. 1986;58(227):305-323.
7. Wickramasinghe SN, Abdalla SH. Blood and bone marrow changes in malaria. Baillieres Best Pract Res Clin Haematol. 2000;13(2):277-299.
8. Casals-Pascual C, Kai O, Cheung JO, et al. Suppression of erythropoiesis in malarial anemia is associated with hemozoin in vitro and in vivo. Blood. 2006;108(8):2569-2577.
9. Chasis JA, Mohandas N. Erythroblastic islands: niches for erythropoiesis. Blood. 2008;112(3):470-478.
10. Wickramasinghe SN, Abdalla S, Weatherall DJ. Cell cycle distribution of erythroblasts in P. falciparum malaria. Scand J Haematol. 1982;29(1):83-88. (Pubitemid 12050221)
11. Schwarzer E, Kühn H, Valente E, Arese P. Malaria-parasitized erythrocytes and hemozoin nonenzymatically generate large amounts of hydroxy fatty acids that inhibit monocyte functions. Blood. 2003;101(2):722-728.
12. Schwarzer E, Müller O, Arese P, Siems WG, Grune T. Increased levels of 4-hydroxynonenal in human monocytes fed with malarial pigment hemozoin. A possible clue for hemozoin toxicity. FEBS Lett. 1996;388(2-3):119-122.
13. Skorokhod O, Schwarzer E, Grune T, Arese P. Role of 4-hydroxynonenal in the hemozoin-mediated inhibition of differentiation of human monocytes to dendritic cells induced by GM-CSF/IL-4. Biofactors. 2005;24(1-4):283-289. (Pubitemid 41750552)
14. Poli G, Schaur RJ, Siems WG, Leonarduzzi G. 4-Hydroxynonenal: a membrane lipid oxidation product of medicinal interest. Med Res Rev. 2008;28(4):569-631.
15. Giribaldi G, Ulliers D, Schwarzer E, Roberts I, Piacibello W, Arese P. Hemozoin- and 4-hydroxynonenal-mediated inhibition of erythropoiesis. Possible role in malarial dyserythropoiesis and anemia. Haematologica. 2004;89(4):492-493.
16. Barrera G, Pizzimenti S, Dianzani MU. 4-Hydroxynonenal and regulation of cell cycle: effects on the pRb/E2F pathway. Free Radic Biol Med. 2004;37(5):597-606. (Pubitemid 38993508)
17. Vousden KH, Prives C. Blinded by the light: the growing complexity of p53. Cell. 2009;137(3):413-431.
18. Abbas T, Dutta A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer. 2009;9(6):400-414.
19. Welch JJ, Watts JA, Vakoc CR, et al. Global regulation of erythroid gene expression by transcription factor GATA1. Blood. 2004;104(3):3136-3147.
20. Giarratana MC, Kobari L, Lapillonne H, et al. Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nat Biotechnol. 2005;23(1):69-74.
21. Piacibello W, Sanavio F, Garetto L, et al. Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood. 1997;89(8):2644-2653. (Pubitemid 27172548)
22. Piacibello W, Sanavio F, Bresso P, et al. Stem cell factor improvement of proliferation and maintenance of hemopoietic progenitors in myelodysplastic syndromes. Leukemia. 1994;8(2):250-257.
23. Andersson LC, Jokinen M, Gahmberg CG. Induction of erythroid differentiation in the human leukaemia cell line K562. Nature. 1979;278(5702):364-365.
24. Skorokhod OA, Alessio M, Mordmueller B, Arese P, Schwarzer E. Hemozoin (malaria pigment) inhibits differentiation and maturation of human monocyte-derived dendritic cells: a peroxisome proliferator-activated receptor-gamma mediated effect. J Imunol. 2004;173(6):4066-4074. (Pubitemid 39280771)
25. Spector DL, Goldman RD, Leinwand LA, eds. Cells: A Laboratory Manual. Cold Spring Harbor, NY: CSH Laboratory Press; 1998.
26. Darzynkiewicz Z, Juan G, Bedner E. Determining cell cycle stages by flow cytometry. Curr Protoc Cell Biol. 2001;Chapter 8:Unit 8.4.
27. Ghaffari S. Oxidative stress in the regulation of normal and neoplastic hematopoiesis. Antioxid Redox Signal. 2008;10(11):1923-1940.
28. Zhang F, Wang W, Tsuji Y, Torti SV, Torti FM. Post-transcriptional modulation of iron homeostasis during p53-dependent growth arrest. J Biol Chem. 2008;283(49):33911-33918.
29. Yu Y, Kovacevic Z, Richardson DR. Tuning cell cycle regulation with an iron key. Cell Cycle. 2007;6(16):1982-1994.
30. Brooks CL, Gu W. Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr Opin Cell Biol. 2003;15(2):164-171. (Pubitemid 36332191)
31. Horvath MM, Wang X, Resnick MA, Bell DA. Divergent evolution of human p53 binding sites: cell cycle versus apoptosis. PLoS Genet. 2007;3(7):e127.
32. Laurora S, Tamagno E, Briatore F, et al. 4-Hydroxynonenal modulation of p53 family gene expression in the SK-N-BE neuroblastoma cell line. Free Radic Biol Med. 2005;38(2):215-225.
33. Cenini G, Sultana R, Memo M, Butterfield DA. Effects of oxidative and nitrosative stress in brain on p53 proapoptotic protein in amnestic mild cognitive impairment and Alzheimer disease. Free Radic Biol Med. 2008;45(1):81-85.
34. Shiraishi K, Naito K. Effects of 4-hydroxy-2-nonenal, a marker of oxidative stress, on spermatogenesis and expression of p53 protein in male infertility. J Urol. 2007;178(3 Pt 1):1012-1017. (Pubitemid 47211068)
35. Chung FL, Nath RG, Ocando J, Nishikawa A, Zhang L. Deoxyguanosine adducts of t-4-hydroxy-2-nonenal are endogenous DNA lesions in rodents and humans: detection and potential sources. Cancer Res. 2000;60(6):1507-1511.
36. Zumbrennen KB, Wallander ML, Romney SJ, Leibhold EA. Cysteine oxidation regulates the RNA-binding activity of iron regulatory protein 2. Mol Cell Biol. 2009;29(8):2219-2229.
37. Levy JE, Jin O, Fujiwara Y, Kuo F, Andrews NC. Transferrin receptor is necessary for development of erythrocytes and the nervous system. Nat Genet. 1999;21(4):396-399.
38. Kulp KS, Green SL, Vulliet PR. Iron deprivation inhibits cyclin-dependent kinase activity and decreases cyclin D/CDK4 protein levels in asynchronous MDA-MB-453 human breast cancer cells. Exp Cell Res. 1996;229(1):60-68.
39. Trainor CD, Mas C, Archambault P, Di Lello P, Omichinski JG. GATA-1 associates and inhibits p53. Blood. 2009;114(1):165-173.
40. Rylski M, Welch JJ, Chen YY, et al. GATA-1-mediated proliferation arrest during erythroid maturation. Mol Cell Biol. 2003;3(14):5031-5042. (Pubitemid 36793347)
41. Miyajima I, Levitt L, Hara T, et al. The murine interleukin-3 receptor alpha subunit gene: chromosomal localization, genomic structure, and promotor function. Blood. 1995;85(5):1246-1253.
42. Kadri Z, Shimizu R, Ohneda O, et al. Direct binding of pRb/E2F-2 to GATA-1 regulates maturation and terminal cell division during erythropoiesis. PLoS Biol. 2009;7(6):e1000123.
43. Wu X, Bishopric NH, Discher DJ, Murphy BJ, Webster KA. Physical and functional sensitivity of zinc finger transcription factors to redox change. Mol Cell Biol. 1996;16(3):1035-1046. (Pubitemid 26061675)
44. Lamikanra AA, Theron M, Kooij TW, Roberts DJ. Hemozoin (malarial pigment) directly promotes apoptosis of erythroid precursors. PLoS ONE. 2009;4(12):e8446.
45. Clark IA, Budd AC, Alleva LM, Cowden WB. Human malarial disease: a consequence of inflammatory cytokine release. Malar J. 2006;5:85.
46. Martiney JA, Sherry B, Metz CN, et al. Macrophage migration inhibitory factor release by macrophages after ingestion of Plasmodium chabaudi-infected erythrocytes: possible role in the pathogenesis of malarial anemia. Infect Immun. 2000;68(4):2259-2267.
47. McGuire W, Knight JC, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. J Infect Dis. 1999;179(1):287-290.
48. Kurtzhals JAL, Adabayeri V, Goka BQ, et al. Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria. Lancet. 1998;351(9118):1768-1772. (Pubitemid 28269187)
49. Awandare GA, Ouma Y, Ouma C, et al. Role of monocyte-acquired hemozoin in suppression of macrophage migration inhibitory factor in children with severe malarial anemia. Infect Immun. 2007;75(1):201-210. (Pubitemid 46047894)
50. Lyke KE, Diallo DA, Dicko A, et al. Association of intraleukocytic P falciparum malaria pigment with disease severity, clinical manifestations, and prognosis in severe malaria. Am J Trop Med Hyg. 2003;69(3):253-259.